Previous 10 | Next 10 |
The following slide deck was published by Pulmonx Corporation in conjunction with their 2021 Q4 earnings call. For further details see: Pulmonx Corporation 2021 Q4 - Results - Earnings Call Presentation
Gainers: Lantheus (NASDAQ:LNTH) +34%. Evolent Health (NYSE:EVH) +18%. Clover Health (NASDAQ:CLOV) +10%. Liquidia (NASDAQ:LQDA) +10%. iRhythm Technologies (NASDAQ:IRTC) +8%. Losers: Orphazyme (NASDAQ:ORPH) -36%. Rhythm Pharmaceuticals (NASDAQ:RYTM) -24%. Tabu...
Pulmonx (NASDAQ:LUNG) stock declined after-hours on Feb. 23 following its Q4 results, where the company provided 2022 revenue outlook to be below analysts' estimates. Q4 total worldwide revenue rose 39% Y/Y to $13.7M. The U.S. revenue was $7.3M, while international revenue was $6.4M...
Image source: The Motley Fool. Pulmonx Corporation (NASDAQ: LUNG) Q4 2021 Earnings Call Feb 23, 2022 , 4:30 p.m. ET Operator Continue reading For further details see: Pulmonx Corporation (LUNG) Q4 2021 Earnings Call Transcript
Pulmonx Corporation (LUNG) Q4 2021 Earnings Conference Call February 23, 2022 16:30 ET Company Participants Glen French - President & Chief Executive Officer Derrick Sung - Chief Financial Officer Conference Call Participants Jason Bednar - Piper Sandler Rick Wise - Stifel Presentation Op...
Pulmonx press release (NASDAQ:LUNG): Q4 GAAP EPS of -$0.35 beats by $0.01. Revenue of $13.7M (+39.8% Y/Y) misses by $0.54M. For further details see: Pulmonx GAAP EPS of -$0.35 beats by $0.01, revenue of $13.7M misses by $0.54M
REDWOOD CITY, Calif., Feb. 23, 2022 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the "Company"), a global leader in minimally invasive treatments for lung disease, today reported financial results for the fourth quarter and full year of 2021 ended Decem...
REDWOOD CITY, Calif., Feb. 10, 2022 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”) a global leader in minimally invasive treatments for severe lung disease, today announced the company will be participating in a fireside chat at the Citi 2022 Virtual Health...
REDWOOD CITY, Calif., Feb. 09, 2022 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments for lung disease, today announced that it will release financial results for the fourth quarter and full year of 2021 after ...
REDWOOD CITY, Calif., Dec. 29, 2021 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”) a global leader in minimally invasive treatments for severe lung disease, today announced the company will present at the upcoming 40 th Annual J.P. Morgan Healthcare Con...
News, Short Squeeze, Breakout and More Instantly...
2024-07-12 22:40:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
REDWOOD CITY, Calif., July 10, 2024 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments for lung disease, today announced that it will release financial results for the second quarter of 2024 after the close of trading...
2024-06-23 01:22:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...